OUTCOME OF FLUOROSCOPY GUIDED PERCUTANEOUS NEPHROLITHOTOMY FOR THE TREATMENT OF RENAL CALCULI

• Main Authors: Tariq Ahmad, Ata ur Rahman
• Format: Article
• Language: English
• Published: Gomal Medical College, D.I.Khan, Pakistan 2014-05-01
• Series: Gomal Journal of Medical Sciences
• Subjects: percutaneous nephrolithotomy; renal calculi; fluoroscopy
• Online Access: http://gjms.com.pk/ojs24/index.php/gjms/article/view/970

Background: Percutaneous Nephrolithotomy is the modality of choice for the surgical management of stones. The objective of this study was to share our experience regarding the safety and efficacy of fluoroscopy guided Percutaneous Nephrolithotomy for the treatment of renal calculi and its post operative complications. Material & Methods: This descriptive study was conducted in Institute of Kidney Diseases, Hayatabad Medical Complex, Peshawar from January 2012 to January 2013 over 103 patients. After fulfilling inclusion criteria baseline investigations were carried out. All patients underwent fluoroscopic guided percutaneous nephrolithotomy. Postoperative X-ray KUB was done to confirm clearance of stones. Results: Out of 103 patients, 67(65.04%) were male and 36(34.95%) female. Mean age of the sample was 33.3±8.5 (15-65) years. Right sided and left sided stones were noted in 62 (60.19%) and 41(48.81%) patients respectively. The mean stone size was 3.9±1.36 (2-6) cm. Access to the PC system was successful in all (100%) cases. The targeted calyces were upper, middle and lower in 29 (28.15%), 16 (15.53%) and 58 (56.31%) patients. The mean operation duration was 75±24.4 (50-165) minutes. The mean hospital stay was 3.9±1.4 (2-5) days. Per-operative stone clearance was in 94 (91.26%) cases. Five (4.85%) patients have presence of residual stone fragments. Seven (6.8%) patients had clinically insignificant residual stones which cleared in 4 weeks time. Overall stone clearance with additional procedures was in 99 (96.12%) cases. Conclusion: Being minimally invasive PCNL is safe and effective treatment for renal calculi associated with less morbidity, shorter hospital stay and is cost effective.